These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 2827796)

  • 1. Antibody prevalence to torch agents in pregnant women and relative risk of congenital infections in Italy (Liguria).
    Canessa A; Pantarotto F; Miletich F; Russo A; Gotta C; Bozzuffi PM; Ferrari G; Fiorelli A; Terragna A
    Biol Res Pregnancy Perinatol; 1987; 8(2 2D Half):84-8. PubMed ID: 2827796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of toxoplasma gondii, rubella virus, cytomegalovirus herpes simplex virus (TORCH) and syphilis in Jamaican pregnant women.
    Prabhakar P; Bailey A; Smikle MF; McCaw-Binns A; Ashley D
    West Indian Med J; 1991 Dec; 40(4):166-9. PubMed ID: 1664562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of TORCH infections in women of childbearing age in Croatia.
    Vilibic-Cavlek T; Ljubin-Sternak S; Ban M; Kolaric B; Sviben M; Mlinaric-Galinovic G
    J Matern Fetal Neonatal Med; 2011 Feb; 24(2):280-3. PubMed ID: 20476874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for TORCH infections in pregnant women: a report from Delhi.
    Kaur R; Gupta N; Nair D; Kakkar M; Mathur MD
    Southeast Asian J Trop Med Public Health; 1999 Jun; 30(2):284-6. PubMed ID: 10774696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serological study of cytomegalovirus, herpes simplex and rubella virus, hepatitis B and Toxoplasma gondii in 2 populations of pregnant women in Santiago, Chile].
    Vial P; Torres-Pereyra J; Stagno S; González F; Donoso E; Alford CA; Hirsch T; Rodríguez L
    Bol Oficina Sanit Panam; 1985 Nov; 99(5):528-38. PubMed ID: 3006719
    [No Abstract]   [Full Text] [Related]  

  • 6. Possible role of TORCH agents in congenital malformations in Gorgan, northern Islamic Republic of Iran.
    Golalipour MJ; Khodabakhshi B; Ghaemi E
    East Mediterr Health J; 2009; 15(2):330-6. PubMed ID: 19554979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of antibodies to rubella, herpes simplex 2 and cytomegalovirus in pregnant women and in neonates at Ga-Rankuwa.
    Bos P; Steele D; Alexander J
    Cent Afr J Med; 1995 Jan; 41(1):14-7. PubMed ID: 7767930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus, cytomegalovirus, herpes simplex virus and parvovirus B19 infection in South-Western Finland.
    Alanen A; Kahala K; Vahlberg T; Koskela P; Vainionpää R
    BJOG; 2005 Jan; 112(1):50-6. PubMed ID: 15663397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence of infectious agents in indigenous women of childbearing age in Venezuela].
    Monsalve-Castillo FM; Costa-León LA; Castellano ME; Suárez A; Atencio RJ
    Biomedica; 2012; 32(4):519-26. PubMed ID: 23715227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological studies on possible causes of intra-uterine infections in Thai infants.
    Tantivanich S; Savanat T; Vongsthongsri U; Manesuwan P
    Southeast Asian J Trop Med Public Health; 1980 Sep; 11(3):387-94. PubMed ID: 6255610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune status to congenital infections by TORCH agents in pregnant Saudi women.
    Hossain A; Bakir TM; Ramia S
    J Trop Pediatr; 1986 Apr; 32(2):83-6. PubMed ID: 3012108
    [No Abstract]   [Full Text] [Related]  

  • 12. Perinatal nonbacterial infections.
    Dutta D
    Clin Lab Med; 1981 Jun; 1(2):377-97. PubMed ID: 6286210
    [No Abstract]   [Full Text] [Related]  

  • 13. TORCH serologies and specific IgM antibody determination in acquired and congenital infections.
    Fung JC; Tilton RC
    Ann Clin Lab Sci; 1985; 15(3):204-11. PubMed ID: 2986514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of serological findings and clinical manifestations of TORCH infections in newborns].
    Wang L; Li KH; Liu H; Liu JY; Li YJ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):283-4. PubMed ID: 15340579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of congenital infection--the TORCH screen is not a legitimate test. Paediatric Infectious Diseases Group of the Australasian Society for Infectious Diseases.
    Garland SM; Gilbert GL
    Med J Aust; 1993 Sep; 159(5):346-8. PubMed ID: 8395645
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnosis of viral infections of the newborn infant.
    Stagno S
    Clin Perinatol; 1981 Oct; 8(3):579-89. PubMed ID: 6273052
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prenatal diagnosis of viral infections. A two year study in Strasbourg].
    Labouret N; Cecille A; Wendling MJ; Fritsch S; Gut JP; Stoll-Keller F
    Pathol Biol (Paris); 1999 May; 47(5):526-30. PubMed ID: 10418033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of maternal screening for toxoplasmosis, rubella, cytomegalovirus and herpes simplex virus infection in cases of fetal growth restriction.
    Yamamoto R; Ishii K; Shimada M; Hayashi S; Hidaka N; Nakayama M; Mitsuda N
    J Obstet Gynaecol Res; 2013 Mar; 39(3):653-7. PubMed ID: 23107457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and risk factors for herpes simplex virus type 2 infection among pregnant women in Israel.
    Dan M; Sadan O; Glezerman M; Raveh D; Samra Z
    Sex Transm Dis; 2003 Nov; 30(11):835-8. PubMed ID: 14603091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infectious immune status in an obstetric population of Pakistani immigrants in Norway.
    Bjerke SE; Vangen S; Holter E; Stray-Pedersen B
    Scand J Public Health; 2011 Jul; 39(5):464-70. PubMed ID: 21339369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.